Market Insights
Cell isolation and separation is the process of separating individual living cells from one another within a biological sample such as blood or tissue. Cell isolation and separation techniques comprise centrifugation, FACS (fluorescence-activated cell sorting), BACS (buoyancy-activated cell sorting), MACS (magnetic-activated cell sorting), and microfluidics or filtration. There are three types of cell separation approaches positive selection, negative selection, and depletion. Increasing funding from the government and biotechnology companies for cell-based research, coupled with growing biotechnology and biopharmaceutical companies, is supporting market growth. For example, the National Institutes of Health (NIH) invested $1,646 million in stem cell research in 2017, with another $1 billion expected to be spent by 2019. In addition, the globally rising prevalence of cancer and infectious diseases, along with augmenting demand for personalized medicine, is anticipated to assist in market growth during the forecast period.
The consumables segment is expected to spearhead the market owing to the repetitive demand for these products for research and diagnostics applications due to their limited durability. Increasing adoption of centrifugation technology for the manufacturing of biopharmaceutical drugs, proteins, vaccines, and antibodies will hold a major chunk of the market in the near future. Based on type, the human cells segment dominates the market due to the rising applications of isolated human cells in biopharmaceutical development, research, and clinical trials.
The presence of major market participants, biopharmaceutical companies, and research laboratories, along with sophisticated infrastructure in the U.S. and Canada, has placed North America in the dominant position. On the other hand, Asia Pacific is expected to register a comparatively higher CAGR from 2018 to 2026 due to the rising prevalence of cancer and infectious diseases among individuals and favorable government support for research activities.
The global cell isolation and separation market is segmented on the following basis:
Global Cell Isolation and Separation Market, by Product, 2016–2026 (US$ Mn)
- Consumables
- Media, Reagents, Kits, and Sera
- Beads
- Disposables
- Instruments
- Centrifuges
- Flow Cytometers
- Magnetic-activated cell sorting (MACS) systems
- Filtration Systems
Global Cell Isolation and Separation Market, by Technique, 2016–2026 (US$ Mn)
- Surface Marker
- Filtration
- Centrifugation
Global Cell Isolation and Separation Market, by Type, 2016–2026 (US$ Mn)
Global Cell Isolation and Separation Market, by Application, 2016–2026 (US$ Mn)
- Research Laboratories and Institutes
- Biotechnology and Biopharmaceutical Companies
- Cell Banks
- Hospital and Diagnostic Laboratories
Global Cell Isolation and Separation Market, by Geography, 2016–2026 (US$ Mn)
- North America
- Europe
- Germany
- France
- Italy
- U.K.
- Russia
- Rest of Europe
- Asia-Pacific
- India
- China
- Japan
- Rest of Asia-Pacific
- Latin America
- Brazil
- Mexico
- Rest of Latin America
- Middle East and Africa
- GCC Countries
- South Africa
- Rest of Middle East and Africa
Key players identified in the global cell isolation and separation market include:
- Thermo Fisher Scientific Inc.
- BD Biosciences
- STEMCELL Technologies, Inc.
- Merck KGaA
- GE Healthcare
- Bio-Rad Laboratories, Inc.
- Terumo BCT, Inc.
- pluriSelect Life Science UG (haftungsbeschränkt) & Co. KG
- Miltenyi Biotec GmbH
- BioLegend, Inc.
This report offers the following:
- Comprehensive overview of the global cell isolation and separation market, including the current market dynamics.
- Elucidation of each market segment based on product approvals, launches, and current and anticipated market dynamics
- Company profiles and the competitive landscape of market leaders operating in the cell isolation and separation market, comprising key products, operating business areas, and financial analysis
